61
Participants
Start Date
January 31, 2016
Primary Completion Date
February 19, 2020
Study Completion Date
February 19, 2020
Irbesartan
Irbesartan: 150 or 300 mg o.d. The up-titration of irbesartan from 150 mg to 300 mg o.d. occur during the first 8 weeks following randomization
Placebo
Placebo o.d. to match 150mg or 300mg irbesartan tablets
AP-HM - Hopital de la Timone, Marseille
CHU DE CAEN - Hopital Cote de Nacre, Caen
CHU DE TOULOUSE - Hopital Purpan, Toulouse
CHU DE TOULOUSE - Hopital Rangueil, Toulouse
CHU DE BORDEAUX - Hopital Saint Andre, Bordeaux
CHU DE MONTPELLIER - Hopital Saint Eloi, Montpellier
CHU DE TOURS - Hopital Trousseau, Chambray-lès-Tours
CHU DE GRENOBLE - Hopital Albert Michallon, Grenoble
CHU DE GRENOBLE - Hopital Couple Enfant, Grenoble
CHU DE NANTES - Hopital Hotel-Dieu, Nantes
CHRU DE NANCY - Institut Lorrain du Coeur et des Vaisseaux, Vandœuvre-lès-Nancy
CHRU DE LILLE - Hopital Claude Huriez, Lille
CHU DE LYON - Hopital Edouard Herriot, Lyon
CHU DE LYON - Hopital Femme Mere Enfant, Bron
AP-HP - Hopital Europeen Georges-Pompidou, Paris
Ministry of Health, France
OTHER_GOV
Assistance Publique - Hôpitaux de Paris
OTHER